Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors.
Article Details
- CitationCopy to clipboard
Hamblin JN, Angell TD, Ballantine SP, Cook CM, Cooper AW, Dawson J, Delves CJ, Jones PS, Lindvall M, Lucas FS, Mitchell CJ, Neu MY, Ranshaw LE, Solanke YE, Somers DO, Wiseman JO
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors.
Bioorg Med Chem Lett. 2008 Jul 15;18(14):4237-41. doi: 10.1016/j.bmcl.2008.05.052. Epub 2008 May 17.
- PubMed ID
- 18539455 [ View in PubMed]
- Abstract
Optimisation of a high-throughput screening hit resulted in the discovery of 4-(substituted amino)-1-alkyl-pyrazolo[3,4-b]pyridine-5-carboxamides as potent and selective inhibitors of Phosphodiesterase 4 (PDE4). Herein, we describe early SAR studies around this novel template highlighting preferred substituents and rationalization of SAR through X-ray crystal structures of analogues bound to the PDE4 active site. Pyrazolopyridine 20a was found to be a potent and selective PDE4 inhibitor which also inhibits LPS induced TNF-alpha production from isolated human peripheral blood mononuclear cells and has an encouraging rat PK profile suitable for oral dosing.
DrugBank Data that Cites this Article
- Polypeptides
Name UniProt ID cAMP-specific 3',5'-cyclic phosphodiesterase 4B Q07343 Details - Binding Properties
Drug Target Property Measurement pH Temperature (°C) 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide cAMP-specific 3',5'-cyclic phosphodiesterase 4B IC 50 (nM) 3.16 N/A N/A Details